Sarcoma  >>  evofosfamide (IMGS-101)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
evofosfamide (IMGS-101) / Molecular Templates, ImmunoGenesis
NCT01381822: Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors

Checkmark TH-302 combination with sunitinib
Nov 2013 - Nov 2012: TH-302 combination with sunitinib
Unknown status
1
58
US
TH-302
Threshold Pharmaceuticals
Advanced Renal Cell Carcinoma, Gastrointestinal Stromal Tumors, Pancreatic Neuroendocrine Tumors
06/14
06/14

Download Options